APA (7th ed.) Citation

D, C., YY, C., H, H., S, L., CT, T., QB, J., . . . YX, C. (2025). Targeting PABPC1: A therapeutic strategy of natural Ganoderma meroterpenoid LZ22 against triple-negative breast cancer proliferation. Pharmacological research, 221, 108004. https://doi.org/10.1016/j.phrs.2025.108004

Chicago Style (17th ed.) Citation

D, Cai, Chen YY, Hu H, Li S, Tao CT, Jiang QB, Hu JT, Jiang J, and Cheng YX. "Targeting PABPC1: A Therapeutic Strategy of Natural Ganoderma Meroterpenoid LZ22 Against Triple-negative Breast Cancer Proliferation." Pharmacological Research 221 (2025): 108004. https://doi.org/10.1016/j.phrs.2025.108004.

MLA (9th ed.) Citation

D, Cai, et al. "Targeting PABPC1: A Therapeutic Strategy of Natural Ganoderma Meroterpenoid LZ22 Against Triple-negative Breast Cancer Proliferation." Pharmacological Research, vol. 221, 2025, p. 108004, https://doi.org/10.1016/j.phrs.2025.108004.